The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFevertree Regulatory News (FEVR)

Share Price Information for Fevertree (FEVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,145.00
Bid: 1,152.00
Ask: 1,159.00
Change: -15.00 (-1.29%)
Spread: 7.00 (0.608%)
Open: 1,120.00
High: 1,161.00
Low: 1,120.00
Prev. Close: 1,160.00
FEVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

18 Nov 2019 07:00

RNS Number : 6602T
Fevertree Drinks PLC
18 November 2019
 

18 November 2019

Fevertree Drinks plc

Grant of Options

Fevertree Drinks plc (the "Company") announces the grant of options over a total of 64,466 ordinary shares of 0.25 pence each ("Ordinary Shares") in the Company with an exercise price of 0.25 pence.

On 8th May 2019, the following options were issued to the Company's Executive Directors, pursuant to the Company's Long Term Incentive Plan ("LTIP"):

Name

Title

Number of share options granted

Performance period

Vesting period

Exercise price

Tim Warrillow

Chief Executive Officer

39,240

1 January 2019 to 31 December 2021

3 years commencing on 8 May 2019

0.25p per share

Andy Branchflower

Finance Director

25,226

1 January 2019 to 31 December 2021

3 years commencing on 8 May 2019

0.25p per share

 

The number of Ordinary Shares stated is the maximum number that could be issued to each Executive Director upon full satisfaction of the performance conditions attached to the 2019 awards.

 

The performance conditions are based on the achievement of targets linked to the Company's FY2021 turnover (as regards 75% of each award) and FY2021 adjusted EBITDA (as regards 25% of each award)

 

Taking account of previous grants, the total number of unvested options held by the Executive Directors detailed in this announcement, pursuant to the Company's LTIP, is as follows:

 

Tim Warrillow - 135,123 share options

Andy Branchflower - 75,395 share options

 

This includes the awards granted in 2017 and 2018, further details of which have been disclosed in the relevant Directors Remuneration Report.

 

For further information:

 

Fevertree Drinks plc

 +44 (0)20 7349 4922

Tim Warrillow, Co-founder and CEO

Andy Branchflower, Finance Director

Oliver Winters, Communications & IR Director

Numis Securities - Nominated Adviser and Broker

+44 (0)20 7260 1000

Garry Levin

Matt Lewis

Hugo Rubinstein

 

Investec Bank plc - Joint Broker

+44 (0)20 7597 5970

David Flin

Alex Wright

David Anderson

 

 

 

Brunswick Group

+44 (0)20 7404 5959

Jonathan Glass

Fiona Micallef-Eynaud

 

 

Notes to Editors:

 

Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 70 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On Trade") as well as selected retail outlets ("Off Trade"). 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them in accordance with the Market Abuse Regulations

1

Details of the persons discharging managerial responsibilities / person closely associated

a)

Name

1. Tim Warrillow

2. Andy Branchflower

2

Reason for the notification

a)

Position/status

1. Chief Executive Officer

2. Finance Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Fevertree Drinks plc

b)

LEI

2138007AJRLHRVQZLD07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 0.25 pence each

 

Identification code

GB00BRJ9BJ26

b)

Nature of the transaction

Grant of options

c)

Price(s) and volume(s)

Exercise Prices per share

Volumes

1. 0.25p

2. 0.25p

1. 39,240

2. 25,226

 

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transaction

8th May 2019

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHDGBDBCSBBGCR
Date   Source Headline
19th Apr 202110:26 amRNSHolding(s) in Company
7th Apr 202111:55 amRNSTotal Voting Rights
7th Apr 20217:00 amRNSHolding(s) in Company
18th Mar 20217:00 amRNSFY20 Preliminary Results to 31 December 2020
1st Mar 20217:00 amRNSTotal Voting Rights
2nd Feb 20217:00 amRNSHolding(s) in Company
1st Feb 20217:00 amRNSTotal Voting Rights
28th Jan 20217:00 amRNSFY20 Trading Update
4th Jan 20211:43 pmRNSTotal Voting Rights
1st Dec 20207:00 amRNSTotal Voting Rights
30th Nov 20207:00 amRNSBlock Listing Return
27th Nov 20203:10 pmRNSHolding(s) in Company
2nd Nov 20207:00 amRNSTotal Voting Rights
1st Oct 20207:00 amRNSTotal Voting Rights
18th Sep 202010:30 amRNSHolding(s) in Company
15th Sep 20201:39 pmRNSDirector/PDMR Shareholding
11th Sep 20209:21 amRNSDirector/PDMR Shareholding
8th Sep 20207:00 amRNSHalf-year Report
1st Sep 202011:07 amRNSTotal Voting Rights
4th Aug 20202:16 pmRNSTotal Voting Rights
14th Jul 20207:00 amRNSTrading Statement
3rd Jul 202011:38 amRNSTotal Voting Rights
18th Jun 202012:36 pmRNSTR1: Notification of Major Holdings
9th Jun 20205:02 pmRNSBlock Listing Return
4th Jun 20203:58 pmRNSResult of AGM
4th Jun 20207:00 amRNSAGM STATEMENT & COVID-19 UPDATE
28th May 20205:00 pmRNSGrant of Options
11th May 20204:37 pmRNS2019 Annual Report and Notice of AGM
29th Apr 20207:00 amRNSDirectorate Change
28th Apr 20204:13 pmRNSTR1: Notification of Major Holdings
23rd Apr 202012:15 pmRNSDirector/PDMR Shareholding
22nd Apr 20207:00 amRNSPreliminary Results
14th Apr 20202:30 pmRNSNotification of Results
8th Apr 20204:14 pmRNSStandard form for Notification of Major Holdings
23rd Mar 202010:59 amRNSFCA letter re Release of Preliminary Results
27th Feb 20207:00 amRNSNotification of Major Holdings
11th Feb 20206:04 pmRNSTR-1: Notification of Major Holdings
10th Feb 20207:00 amRNSDirector/PDMR Shareholding
28th Jan 20205:23 pmRNSTR1: Notification of Major Holdings
23rd Jan 20204:34 pmRNSTR-1: Notification of major holdings
23rd Jan 20207:00 amRNSDirector/PDMR Shareholding
22nd Jan 20204:35 pmRNSTR-1: Notification of major holdings
22nd Jan 202012:15 pmRNSTR-1: Notification of major holdings
20th Jan 20207:00 amRNSYear End Trading Update
8th Jan 20202:19 pmRNSNotification of major holdings
3rd Jan 20203:31 pmRNSTR-1: Standard form notification of major holdings
29th Nov 20197:00 amRNSDirector Disclosure
20th Nov 20197:00 amRNSTrading Update
18th Nov 20197:00 amRNSDirector/PDMR Shareholding
6th Nov 20195:43 pmRNSBlock Listing Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.